CLINICAL_TRIALS
trial_result
· 2025-01-07
Clinical Trial Update: QA102 Phase II Study in Subjects With Dry AMD [Phase 2]
Summary
QA102 Phase II trial in Dry age-related macular degeneration has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Smilebiotek Zhuhai Limited | Conditions: Dry Age-related Macular Degeneration | Phase 2 | Status: COMPLETED